Medical News

RSS

Aegis releases Discoverant 4.0 manufacturing intelligence software

Aegis Analytical Corp., the leading provider of Enterprise Manufacturing and Process Intelligence software, announced today the availability of Aegis Discoverant® 4.0, the latest version of its global software platform.

18 Jan 2011

Brush Engineered Materials to become Materion Corporation

Brush Engineered Materials Inc. today announced it will change its name to Materion Corporation and unify all of its businesses under the new name effective March 8, 2011. The Company's common stock will continue to trade on the New York Stock Exchange.

18 Jan 2011

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.

18 Jan 2011

PositiveID and RFID Solutions complete development of temperature-sensing microchip

PositiveID Corporation announced today that it has completed the development of its temperature-sensing microchip in conjunction with development partner RFID Solutions of Malaga, Spain. The microchip, which uses radio frequency identification (RFID) technology, is able to measure internal temperature within the body and communicate that temperature wirelessly to an external reader.

18 Jan 2011

Sinobiomed announces sale of Wanxin and subsidiaries

The Board of Directors of Sinobiomed Inc. is pleased to announce the sale of the Company's wholly-owned BVI subsidiary, Wanxin Bio-Technology Limited and its Chinese subsidiaries, Shanghai Wanxin Bio-Pharmaceutical Co Ltd. and Shanghai Bio-Science Cosmetic Co Ltd.

18 Jan 2011

Emerus obtains $30 million growth capital from Austin Ventures

Emerus Hospital Partners, LLC, a system of Texas-based specialty hospitals, is set to expand the company's operations. Emerus Hospital Partners has obtained growth capital of $30 million from Austin Ventures, one of the nation's leading venture and growth capital firms. The capital will be used to support the company's aggressive expansion plan as well as mergers and acquisitions.

18 Jan 2011

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).

18 Jan 2011

Healthcare Information Xchange of New York completes implementation of InterSystems HealthShare HIE platform

InterSystems Corporation, the global leader in software for connected health care, today announced that the Healthcare Information Xchange of New York (HIXNY) has completed implementation of InterSystems HealthShare™ as its core health information exchange (HIE) platform.

18 Jan 2011

Cardiac surgery market to reach over $4.4 billion by 2017

According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, percutaneous aortic valve replacement (PAVR) and percutaneous mitral valve repair (PMVR) devices are expected to enter the U.S. market in 2011 and grow to almost $1.3 billion by 2017.

18 Jan 2011

Centinel Spine reports record fourth quarter revenue

Centinel Spine, Inc., a market leader in the development, manufacture and distribution of Integrated Interbody Fusion™ devices, today announced a record 41.8% revenue increase during the 4th quarter, 2010, vs. 3rd quarter, 2010. Also, during the 4th quarter, 2010, Centinel achieved a record setting 32.5% gain vs. the same period in 2009.

18 Jan 2011

HAP to provide medical billing services to Lenox Hill Radiology

Healthcare Administrative Partners (HAP), an industry-leading medical billing company, announced today that it has signed a contract to provide medical billing services to Lenox Hill Radiology. Lenox Hill Radiology is a radiologist-owned and operated imaging center located on the Upper East Side of Manhattan. Radiology billing is one of HAP's primary healthcare specialties; the company serves a broad range of hospital-based practices and imaging centers.

18 Jan 2011

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.

18 Jan 2011

FDA grants CASMED 510(k) clearance for expanded labeling of FORE-SIGHT Absolute Tissue Oximeter

CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.

18 Jan 2011

Vocollect to be acquired by Intermec for $190 million in cash

Riverside Partners,, a Boston-based private equity firm, announced today that its portfolio company Vocollect, Inc. has entered into a definitive agreement to be acquired by Intermec, Inc. for US $190 M in cash. Vocollect is the world leader in voice solutions for workforce management of mobile workers.

18 Jan 2011

Transcept announces Intermezzo NDA resubmission for treatment of middle of the night awakenings

Transcept Pharmaceuticals, Inc. today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of Intermezzo® for use as needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.

18 Jan 2011

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.

18 Jan 2011

ONC awards Accenture healthcare IT interoperability contract

The Office of the National Coordinator for Health Information Technology (ONC) awarded Accenture a two-year contract to help identify the standards and specifications that facilitate the exchange of data across the evolving healthcare system.

18 Jan 2011

Liberator Medical 2010 net revenues increase 58.5% to $40,919,000

Liberator Medical Holdings, Inc. announced net revenues for fiscal year 2010 of $40,919,000, an increase of $15,101,000, or 58.5%, compared with fiscal year 2009. The increase in sales was primarily due to the Company's continued emphasis on its direct response advertising campaign. Liberator's direct response advertising expenditures for fiscal year 2010 increased by $6,617,000, or 157.9%, to $10,808,000, compared with fiscal year 2009.

18 Jan 2011

China Nepstar Chain Drugstore declares special cash dividend

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a special cash dividend of US$0.30 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31 million.

18 Jan 2011

Wisepower acquires Unidym

Arrowhead Research Corporation today announced that its Unidym, Inc. subsidiary has been acquired by Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based electronics company. Upfront consideration to Unidym shareholders consists of Wisepower stock and convertible bonds valued at US $5,000,000 with certain restrictions as to timing of stock sales.

18 Jan 2011